雑誌文献を検索します。書籍を検索する際には「書籍検索」を選択してください。

検索

書誌情報 詳細検索 by 医中誌

Japanese

Therapeutic Strategies for Hereditary Transthyretin Amyloidosis Mitsuharu Ueda 1 1Department of Neurology, Graduate School of Medical Sciences, Kumamoto University Keyword: 遺伝性ATTRアミロイドーシス , トランスサイレチン , 疾患修飾療法 , 遺伝子サイレンシング療法 , 核酸医薬 , hereditary ATTR amyloidosis , transthyretin , disease-modifying therapies , gene silencing therapy , nucleic acid medicine pp.539-541
Published Date 2023/5/1
DOI https://doi.org/10.11477/mf.1416202374
  • Abstract
  • Look Inside
  • Reference

Abstract

Disease-modifying therapies such as transthyretin (TTR) gene-silencing drugs and TTR tetramer stabilizers have been developed for hereditary transthyretin (ATTR) amyloidosis, a major type of autosomal dominant hereditary amyloidosis. Recently, a second-generation TTR gene-silencing drug, vutrisiran, was approved for treating patients with hereditary ATTR amyloidosis in Japan. This new drug significantly reduced the patient's physical burden.


Copyright © 2023, Igaku-Shoin Ltd. All rights reserved.

基本情報

電子版ISSN 1344-8129 印刷版ISSN 1881-6096 医学書院

関連文献

もっと見る

文献を共有